Caribou Biosciences Ratios (2020-2025) | CRBU

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin (Quarter)
-829.70%-969.58%-527.38%-709.57%-782.77%-678.22%-803.42%-828.22%-888.52%-875.31%-61.84%-1,052.33%-1,893.87%-1,255.80%-1,889.23%-1,871.69%-1,823.76%-1,783.95%-1,337.58%-721.97%
EBIT Margin (Quarter)
-830.71%-1,081.57%-468.09%-797.38%-782.77%-678.22%-803.42%-828.22%-888.52%-875.31%-61.84%-1,052.33%-1,893.87%-1,255.80%-1,889.23%-1,871.69%-1,823.76%-1,783.95%-1,337.58%-721.97%
EBITDA Margin (Quarter)
-829.70%-969.58%-527.38%-727.39%-752.33%-648.59%-820.50%-717.01%-778.30%-796.94%-41.62%-941.37%-1,712.06%-1,088.16%-1,658.89%-1,734.42%-1,703.31%-2,033.18%-1,250.91%-671.86%
Operating Margin (Quarter)
-830.71%-1,081.57%-468.09%-797.38%-782.77%-678.22%-803.42%-828.22%-888.52%-875.31%-61.84%-1,052.33%-1,893.87%-1,255.80%-1,889.23%-1,871.69%-1,823.76%-1,783.95%-1,337.58%-721.97%
Net Margin (Quarter)
-829.70%-969.58%-527.38%-722.12%-782.77%-678.22%-803.42%-828.22%-888.52%-875.31%-61.84%-1,052.33%-1,893.87%-1,255.80%-1,889.23%-1,871.69%-1,823.76%-1,783.95%-1,337.58%-721.97%
FCF Margin (Quarter)
1,279.38%-1,173.64%-361.23%-908.25%-840.69%-521.40%-678.96%-690.95%-855.80%-418.54%-113.19%-911.64%-1,566.65%-929.27%-1,820.55%-1,534.04%-1,565.66%-1,109.97%-1,080.85%-562.07%
Efficiency
Assets Average (Quarter)
310.18M452.16M444.18M433.68M410.10M386.29M360.61M348.55M403.58M444.87M419.52M389.88M358.64M328.82M293.48M247.28M207.94M185.18M
Equity Average (Quarter)
-29.56M-41.69M178.35M396.11M379.81M359.84M336.00M312.49M289.57M273.87M333.86M383.33M355.85M326.88M295.83M267.08M235.09M191.68M153.99M132.01M
Invested Capital (Quarter)
-35.69M-47.69M404.40M387.82M371.80M347.89M324.11M300.87M278.27M269.46M398.27M368.40M343.29M310.46M281.20M252.95M217.22M166.13M141.84M122.17M
Asset Utilization Ratio (Quarter)
0.030.020.020.030.030.040.040.040.090.080.080.080.030.030.030.040.040.06
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-0.01M
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)
-0.300.880.880.830.830.810.800.800.770.870.850.840.830.820.810.790.750.730.70
Times Interest Earned (Quarter)
-0.01M
Valuation
Enterprise Value (Quarter)
-145.92M-0.05M-435.31M-375.83M-353.73M-339.92M-293.37M-247.66M-228.54M-259.23M-338.49M-328.83M-293.99M-261.65M-228.18M-209.54M-208.47M-183.95M-147.26M-139.34M
Return Ratios
Return on Sales (Quarter)
-0.08%-0.10%-0.05%-0.07%-0.08%-0.07%-0.08%-0.08%-0.09%-0.09%-0.01%-0.11%-0.19%-0.13%-0.19%-0.19%-0.18%-0.18%-0.13%-0.07%
Return on Capital Employed (Quarter)
-22.17%-15.99%-18.16%-21.81%-25.24%-29.71%-34.98%-38.54%-28.81%-27.86%-33.53%-39.44%-50.60%-55.88%-61.71%-76.74%-88.26%-92.85%
Return on Invested Capital (Quarter)
0.01%0.01%0.00%0.00%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%
Return on Equity (Quarter)
0.01%0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%